Fast and Simultaneous Analysis of Ethanol Metabolites and Barbiturates

Feb 16, 2017 | Blogs, Forensic | 0 comments

While most analytes in forensic applications analyze well with positive ionization, there are analytes that show better ionization efficiency with negative ionization, for example, acidic compounds. These analytes include ethanol metabolites such as ethyl glucuronide (ETG), ethyl sulfate (ETS), and the barbiturates such as amobarbital, butabarbital, butalbital, pentobarbital, phenobarbital, and secobarbital.

 

In this technical note, researchers demonstrated a method to simultaneously analyze ethanol metabolites and barbiturates in human urine using QTRAP®/Triple Quad 4500 LC-MS/MS system. Sample preparation is based on a simple “dilute and shoot” methodology. The method has a total runtime of 5 minutes, shows good sensitivity and is very robust. More than 800 continuous injections of human urine samples were performed on a single LC column with no deterioration in performance evident.

How does this test play out in real-world scenarios? ETG and ETS are biomarkers for determining the presence of alcohol over the past 80 hours where ETG is the direct metabolite of alcohol. ETG is only detected if alcohol has been consumed. What is more is that urine tests are the most common and inexpensive choice when testing for drug use and can be easily captured. Making sure results stand up in court, but also being able to run simultaneous drug screenings will help your lab keep up with sample workloads while also producing reliable results.

Why SCIEX partners with experts around the world

Innovation in mass spectrometry does not happen in isolation. Some of the most impactful scientific advances emerge from highly specialized research communities – proteomics experts developing new peptide identification workflows, metabolomics researchers curating spectral databases, toxicologists building compound libraries, and biopharma scientists creating novel characterization methods.

Managing ADC characterization: The challenge of turning complexity into confidence

Unlike traditional monoclonal antibodies, ADCs combine an antibody backbone with linker chemistry and a cytotoxic payload. This multi-component architecture introduces overlapping layers of heterogeneity, including drug-to-antibody ratio (DAR) distributions, charge variants, post-translational modifications, and structural changes at both the intact and subunit levels. Across ADC development, these characteristics are considered critical quality attributes that must be characterized, understood, and monitored.

3 reasons ZT Scan DIA is changing the game in metabolomics

For years, metabolomics researchers have faced a frustrating reality: modern high-resolution mass spectrometers can detect tens of thousands of molecular features, yet only a fraction can be confidently identified. The challenge is no longer finding molecules. It is generating the high-quality MS/MS data needed to confidently assign structures and extract meaningful biological insights.

Posted by

0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network